MHRA consulting for ‘no deal’ Brexit

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is consulting on proposed changes to the way it would regulate medicinal products in the country in the event of a ‘no deal’ UK exit from the European Union (EU) on 29 March 2019.